Occupation: Research House
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants.
Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries.
Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584).
Run by a team of highly experienced professionals, our aim is to provide the research of choice for companies, investment banks and institutional investors. We provide independent reports, forecasts and valuations on each company we cover. We help clients gain access to investors, and facilitate feedback from the investment community on companies, their management and strategies. Our research strives to be objective, insightful, financially rigorous, readable and timely.
Web Address: http://www.edisongroup.com
280 High Holborn
Tel: Tel: +44 (0)20 3077 5700
YouGov is focused on growing its Data Products and Services, which generated half of operating profits in FY14, recently reported. Brand Index and Omnibus lead the way, giving competitive advantage and delivering higher margins than custom research. With the breadth and depth of data derived from the group’s close relationship with its own panellists, assembled in a unified resource, YouGov can derive powerful contextual information.…
European Assets Trust (EAT) is a concentrated portfolio of 43 (at 30 September) small- and mid-cap European companies chosen for their growth or re-rating potential. It has a high distribution policy, paying out 6% of its 31 December NAV as a dividend in three instalments. While 2014 has seen lacklustre returns from Europe, EAT has a strong longer-term record of share price and NAV performance…
Adler Real Estate’s development continues to be at a rapid pace. Since we published our initiation note, exploring the financial impact of management’s growth plans in the period to the end of 2016, on 23 October 2014, a number of important developments have already been announced. Progress on non-core asset sales, completion of the 4,300 unit residential acquisition agreed by Estavis and the agreed acquisition…
Heartland New Zealand was created by merger in January 2011 and focuses on providing financial services to its core markets of SMEs, rural (ie farms, farm machinery and livestock) and households. It focuses on the less contested sectors to achieve a better risk/return balance. As a result, Heartland achieves an average interest margin of 4-5% compared to the larger banks of c 2%. It currently…
Mesoblast’s product pipeline continues to mature as key milestones are met. The filing of MSC-100-IV in graft vs host disease (GvHD) in Japan in early October marks its first product submission. Phase III trials started early this year for MPC-150-IM in congestive heart failure (CHF), while Phase III trials for MPV-06-ID in low back pain are expected to start by the end of 2014 following…